-
Core One Labs completes acquisition of Akome Biotech
expresspharma
May 07, 2021
Akome’s proprietary cGMP drug formulations comprising psychedelic compounds and plant bioactives distinguish its approach on the psychedelic treatment of neurological disorders from other companies.
-
Clean Biologics Acquires Biodextris
contractpharma
May 06, 2021
Clean Biologics, a group providing services to the biopharmaceutical industry, has acquired Biodextris, a contract development and manufacturing organization (CDMO) based in Laval (Montreal), Canada.
-
Hilco Industrial Acquires Machinery & Equipment from Legacy Pharmaceuticals
contractpharma
April 30, 2021
Hilco Industrial Acquisitions, an Amsterdam-based Industrial Asset Disposition and Acquisition Company, has acquired all machinery and equipment from the Swiss-based contract manufacturing organization (CMO) Legacy Pharmaceuticals.
-
Blue Water Acquisition Merges with Clarus Therapeutics
americanpharmaceuticalreview
April 29, 2021
Clarus Therapeutics Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, and Blue Water Acquisition Corp., a special purpose acquisition company (SPAC) ...
-
Frontage Acquires Ocean Ridge Biosciences
contractpharma
April 22, 2021
Frontage Laboratories, Inc., has expanded its genomic services through the acquisition of Ocean Ridge Biosciences.
-
Resilience Acquires Ology Bioservices
contractpharma
April 20, 2021
National Resilience, Inc., a company that says it is building a biopharmaceutical manufacturing ecosystem, has acquired Ology Bioservices, a privately held company that also specializes in biologic drug substance manufacturing from early stage ...
-
AstraZeneca Receives US Clearance of Proposed Acquisition of Alexion
americanpharmaceuticalreview
April 19, 2021
AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an important step toward completion, having cleared US Federal Trade Commission review.
-
Amgen Completes Five Prime Acquisition
contractpharma
April 19, 2021
Amgen has completed its acquisition of Five Prime Therapeutics for approximately $1.9 billion in cash. This acquisition adds Five Prime's innovative pipeline of immuno-oncology and targeted cancer therapies to Amgen's oncology portfolio.
-
Thermo Fisher Acquires PPD for $17.4B
contractpharma
April 16, 2021
Thermo Fisher Scientific has acquired clinical research services provider PPD for $17.4 billion.
-
Cryoport Acquires Critical Transport Solutions Australia
contractpharma
April 08, 2021
Cryoport, Inc., a global provider of temperature-controlled supply chain solutions for the life sciences, has acquired Critical Transport Solutions Australia Pty Ltd. (CTSA), a provider of healthcare logistics management services, for approximately ...